Celimmune: <b>Celimmune</b> To Present Experimental Anti-IL-15 Antibody AMG 714 At <b>16th International Coeliac Disease Symposium</b>

LEBANON, N.J. and BETHESDA, Md., June 22, 2015 /PRNewswire/ --Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, announced today that Dr. Francisco Leon, CEO and Chief Medical...